Considerably decreased risk of cardiovascular disease with combined reductions in HbA1c, blood pressure and blood lipids in type 2 diabetes: Report from the Swedish National Diabetes Register

Diabetes care – improvement through measurement

(2014) Björn Eliasson et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Low-Risk Diet and Lifestyle Habits in the Primary Prevention of Myocardial Infarction in Men

(2014) Agneta Åkesson et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

(2013)   EUROPEAN HEART JOURNAL

Independent Contribution of A1C, Systolic Blood Pressure, and LDL Cholesterol Control to Risk of Cardiovascular Disease Hospitalizations in Type 2 Diabetes: An Observational Cohort Study

(2013) Gregory A. Nichols et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

2013 ESH/ESC Guidelines for the management of arterial hypertension

(2013) Giuseppe Mancia et al.   JOURNAL OF HYPERTENSION

Blood pressure and risk of cardiovascular diseases in type 2 diabetes

(2012) Jan Cederholm et al.   JOURNAL OF HYPERTENSION

Clinical Usefulness of Different Lipid Measures for Prediction of Coronary Heart Disease in Type 2 Diabetes: A report from the Swedish National Diabetes Register

(2011) B. Eliasson et al.   DIABETES CARE

Additive effects of glycaemia and dyslipidaemia on risk of cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register

(2011) S. Gudbjörnsdottir et al.   DIABETOLOGIA

Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds

(2011) S. Zoungas et al.   DIABETOLOGIA

Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes

(2010) M.-R. Taskinen et al.   DIABETOLOGIA

Tight Blood Pressure Control and Cardiovascular Outcomes Among Hypertensive Patients With Diabetes and Coronary Artery Disease

(2010) Rhonda M. Cooper-DeHoff et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR)

(2010) K. Eeg-Olofsson et al.   JOURNAL OF INTERNAL MEDICINE

Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes: New results from the ADVANCE trial

(2009) S. Zoungas et al.   DIABETES CARE

Effect of tight control of HbA1c and blood pressure on cardiovascular diseases in type 2 diabetes: An observational study from the Swedish National Diabetes Register (NDR)

(2009) Jan Cederholm et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Intensive glucose control and macrovascular outcomes in type 2 diabetes

(2009) F. M. Turnbull et al.   DIABETOLOGIA

Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart

(2009) Matteo Anselmino et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

Statistical Methods for Monitoring the Relationship between the IFCC Reference Measurement Procedure for Hemoglobin A1c and the Designated Comparison Methods in the United States, Japan, and Sweden

(2008) A. Geistanger et al.   CLINICAL CHEMISTRY

Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis

(2008)   LANCET

Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes

(2008) Peter Gæde et al.   NEW ENGLAND JOURNAL OF MEDICINE